Pearl J M, Laks H, Drinkwater D C, Meneshian A, Sun B, Gates R N, Chang P
Department of Surgery, University of California, Los Angeles Medical Center 90024.
J Thorac Cardiovasc Surg. 1993 Feb;105(2):201-6.
Although standard blood cardioplegia provides good myocardial protection for cardiac operations in adults, protection of the cyanotic, immature myocardium remains suboptimal. Calcium, which has been implicated in reperfusion injury and in the development of "stone heart" in mature myocardium, is routinely lowered in standard cardioplegic solutions. Immature, neonatal myocardium has lower intracellular calcium stores and is more reliant on extracellular calcium for contraction. To determine if normocalcemic cardioplegia would result in improved cardiac function in the neonatal heart, we conducted a series of experiments using an isolated, blood-perfused working heart model. Thirty-two neonatal piglet hearts (24 to 48 hours) were excised without intervening ischemia and were placed directly on a blood-perfused circuit. Baseline stroke work index was assessed. Hearts were then arrested with cold cardioplegic solution delivered at 45 mm Hg for 2 minutes: group I, low-calcium blood cardioplegic solution (Ca = 0.6 mmol/L); group II, normal-calcium blood cardioplegic solution (Ca = 1.1 mmol/L); group III, University of Wisconsin solution; and group IV, University of Wisconsin solution with added calcium (Ca = 1.0 mmol/L). Cardioplegic solution was administered every 20 minutes for 2 hours and topical hypothermia was used. Hearts were then reperfused with warm whole blood. Functional recovery, expressed as a percentage of control stroke work index, was determined minutes after reperfusion. Hearts preserved with normocalcemic cardioplegic solution (groups II and IV) had complete functional recovery at 60 minutes, whereas hearts preserved with low-calcium cardioplegic solution (groups I and III) achieved functional recoveries of only 80% and 65%, respectively, at a left atrial pressure of 9 mm Hg. Electron micrographs taken 1 hour after reperfusion showed minimal edema and only mild myofibrillar changes. They were identical in both the low-calcium and normocalcemic groups. Complete functional recovery is possible in immature myocardium when calcium is added to either blood or an intracellular crystalloid cardioplegic solution. The addition of calcium does not result in ultrastructural damage and does result in good functional recovery.
尽管标准血液停搏液能为成人心脏手术提供良好的心肌保护,但对青紫、未成熟心肌的保护仍不尽人意。钙与再灌注损伤以及成熟心肌中“石心”的形成有关,在标准停搏液中通常会降低钙的浓度。未成熟的新生儿心肌细胞内钙储备较低,收缩更依赖细胞外钙。为了确定正常钙浓度的停搏液是否能改善新生儿心脏的功能,我们使用离体、血液灌注的工作心脏模型进行了一系列实验。32个新生仔猪心脏(出生24至48小时)在无缺血干预的情况下被切除,直接置于血液灌注回路中。评估基础每搏功指数。然后用45mmHg的冷停搏液灌注2分钟使心脏停搏:第一组,低钙血液停搏液(Ca = 0.6mmol/L);第二组,正常钙浓度血液停搏液(Ca = 1.1mmol/L);第三组,威斯康星大学溶液;第四组,添加钙的威斯康星大学溶液(Ca = 1.0mmol/L)。每20分钟给予停搏液,持续2小时,并采用局部低温。然后用温全血进行再灌注。再灌注后几分钟测定功能恢复情况,以对照每搏功指数的百分比表示。用正常钙浓度停搏液保存的心脏(第二组和第四组)在60分钟时功能完全恢复,而用低钙停搏液保存的心脏(第一组和第三组)在左心房压力为9mmHg时,功能恢复分别仅为80%和65%。再灌注1小时后的电子显微镜照片显示水肿轻微,仅肌原纤维有轻度改变。低钙组和正常钙浓度组的情况相同。当向血液或细胞内晶体停搏液中添加钙时,未成熟心肌有可能实现完全功能恢复。添加钙不会导致超微结构损伤,且确实能实现良好的功能恢复。